# A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

> **NCT01280981** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 288 (actual)

## Conditions studied

- Menorrhagia

## Interventions

- **DRUG:** Tranexamic acid

## Key facts

- **NCT ID:** NCT01280981
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2011-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280981, "A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01280981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*